Genetic perspectives on the serotonin transporter

Brain Research Bulletin

Volumn 56, Issue 5, 2001, Pages 487-494

  Murphy, Dennis L ^a,e   Li, Qian ^a   Engel, Sharon ^a   Wichems, Christine ^a   Andrews, Anne ^b   Lesch, Klaus Peter ^c   Uhl, George ^d  

^a NATIONAL INSTITUTE OF MENTAL HEALTH   (United States)

^b PENNSYLVANIA STATE UNIVERSITY   (United States)

^c UNIVERSITY OF WÜRZBURG   (Germany)

^d NATIONAL INSTITUTE ON DRUG ABUSE   (United States)

^e NATIONAL INSTITUTES OF HEALTH   (United States)

Author keywords

Neuropsychiatric disorders; Personality; Polymorphisms; Serotonin; Transgenic (knockout mutant) mice

Indexed keywords

AMPHETAMINE; BENZODIAZEPINE DERIVATIVE; CITALOPRAM; DESIPRAMINE; FLUOXETINE; FLUVOXAMINE; METHYLPHENIDATE; PAROXETINE; SEROTONIN TRANSPORTER; SEROTONIN UPTAKE INHIBITOR; SERTRALINE;

ANXIETY; BEHAVIOR; CONFERENCE PAPER; GENE EXPRESSION; GENETIC POLYMORPHISM; HUMAN; MENTAL DISEASE; NEUROPSYCHIATRY; NONHUMAN; PRIORITY JOURNAL; PROMOTER REGION; TEMPERAMENT;

ANIMALS; CARRIER PROTEINS; CENTRAL NERVOUS SYSTEM; DISEASE MODELS, ANIMAL; HUMANS; MEMBRANE GLYCOPROTEINS; MEMBRANE TRANSPORT PROTEINS; MENTAL DISORDERS; MICE; MICE, KNOCKOUT; NERVE TISSUE PROTEINS; RECEPTORS, SEROTONIN; SEROTONIN; SEROTONIN PLASMA MEMBRANE TRANSPORT PROTEINS; SEROTONIN UPTAKE INHIBITORS;

EID: 0035891885     PISSN: 03619230     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0361-9230(01)00622-0     Document Type: Conference Paper

References (99)

1. Multipoint quantitative-trait linkage analysis in general pedigrees
2. Fluoxetine and desipramine selectively attenuate 2′-NH2-MPTP-induced depletions in serotonin and norepinephrine
3. Sustained depletion of cortical and hippocampal serotonin and norepinephrine but not striatal dopamine by 1-methyl-4-(2′-aminophenyl)-1,2,3,6-tetrahydropyridine (2′-NH2-MPTP): A comparative study with 2′-CH3-MPTP and MPTP
4. A microdialysis study of the effects of high K+ and paroxetine on extracellular serotonin concentrations in serotonin transporter knock-out mice
5. Opposite modulatory effects of ovarian hormones on rat brain dopamine and serotonin transporters
6. The power of genomic control
7. A review of central 5-HT receptors and their function
8. Tryptophan depletion in patients with obsessive-compulsive disorder who respond to serotonin reuptake inhibitors
9. Possible association between serotonin transporter gene polymorphism and violent suicidal behavior in mood disorders
10. Association of the serotonin transporter promoter regulatory region and obsessive-compulsive disorder
11. Altered brain serotonin homeostasis and locomotor insensitivity to 3, 4-methylenedioxymethamphetamine ("Ecstasy") in serotonin transporter-deficient mice
12. The relationship of obsessive-compulsive disorder to possible spectrum disorders: Results from a family study
13. Obsessive compulsive disorder, response to serotonin reuptake inhibitors and the serotonin transporter gene
14. Biogenic amine transporters: Regulation in flux
15. Mouse models of serotonin receptor function: Toward a genetic dissection of serotonin systems
16. Chronic administration of serotonergic antidepressants attenuates the subjective effects of LSD in humans
17. Plasma membrane transporters of serotonin, dopamine, and norepinephrine mediate serotonin accumulation in atypical locations in the developing brain of monoamine oxidase A knock-outs
18. Birth outcomes in pregnant women taking fluoxetine
19. Possible existence of quaternary structure in the high-affinity serotonin transport complex
20. A functional neuroanatomy of anxiety and fear: Implications for the pathophysiology and treatment of anxiety disorders
21. Maintenance of serotonin in the intestinal mucosa and ganglia of mice that lack the high affinity serotonin transporter (SERT): Abnormal intestinal motility and the expression of cation transporters
22. Induction of long-term facilitation in Aplysia sensory neurons by local application of serotonin to remote synapses
23. Biological bases of anxiety
24. Comparison of the role of dopamine, serotonin, and noradrenaline genes in ADHD, OCD and conduct disorder: Multivariate regression analysis of 20 genes
25. Evidence of linkage between the serotonin transporter and autistic behavior
26. 5-Hydroxytryptamine in the pathogenesis of affective disorders
27. Exploratory behavior models of anxiety in mice
28. Delivery outcome after the use of antidepressants in early pregnancy
29. A simple genetic basis for a complex psychological trait in laboratory mice
30. Population studies of polymorphisms of the serotonin transporter protein gene
31. Modifications of the serotoninergic system in mice lacking serotonin transporters. An in vivo electrophysiological study
32. Effects of third trimester fluoxetine exposure on the newborn
33. Serotonin transporter gene polymorphisms, alcoholism, and suicidal behavior
34. Association between the serotonin transporter promoter polymorphism and personality traits in a primarily female population sample
35. Genetic variation in the serotonin transporter promoter region affects serotonin uptake in human blood platelets
36. 5-Hydroxytryptamine-interacting drugs in animal models of anxiety disorders: More than 30 years of research
37. Variability in the effects of 5-HT-related compounds in experimental models of anxiety: Evidence for multiple mechanisms of 5-HT in anxiety or never ending story?
38. Acute and chronic treatment with 5-HT reuptake inhibitors differentially modulate emotional responses in anxiety models in rodents
39. 5-Hydroxytryptamine pathways in anxiety and its treatment
40. 5-HT drugs in animal models of anxiety
41. Serotonin transporter messenger RNA in the developing rat brain: Early expression in serotonergic neurons and transient expression in non-serotonergic neurons
42. Serotonin transporter messenger RNA expression in neural crest-derived structures and sensory pathways of the developing rat embryo
43. The human serotonin transporter gene polymorphism - Basic research and clinical implications
44. Allelic variation of human serotonin transporter gene expression
45. Functional characterization of the murine serotonin transporter gene promoter in serotonergic raphe neurons
46. Promises and limitations of transgenic and knockout mice in modeling psychiatric symptoms
47. Increased anxiety-like behavior in mice lacking the 5-HT transporter
48. An association study of a functional polymorphism of the serotonin transporter gene with personality and psychiatric symptoms
49. Sources of individual differences in depressive symptoms: Analysis of two samples of twins and their families
50. A twin-family study of self-report symptoms of panic-phobia and somatization
51. Serotonin transporter gene polymorphism and antidepressant response
52. Parametric and nonparametric linkage analysis: A unified multipoint approach
53. A double-blind desipramine substitution during long-term clomipramine treatment in children and adolescents with obsessive-compulsive disorder
54. Association of anxiety-related traits with a polymorphism in the serotonin transporter gene regulatory region
55. Serotonin transporter, personality, and behavior: Toward dissection of gene-gene and gene-environment interaction
56. Genetically driven variation in serotonin uptake: Is there a link to affective spectrum, neurodevelopmental, and neurodegenerative disorders?
57. Primary structure of the human platelet serotonin uptake site: Identity with the brain serotonin transporter
58. 1A receptors in 5-HT transporter knockout mice: Gender and brain region differences
59. 1A binding sites in 5-HT transporter knockout mice
60. Cloning and characterization of two related serotonergic receptors from the brain and the reproductive system of aplysia that activate phospholipase C
61. Cocaine, ethanol, and genotype effects on human midbrain serotonin transporter binding sites and mRNA levels
62. DAT, SERT and DATSERT knockout mice: Microarray analyses of gene expression
63. Effects of serotonin transporter inactivation on extracellular 5-HT levels, in vivo microdialysis recovery and MDMA-induced release of serotonin and dopamine in mouse striatum
64. Role of the serotonin transporter promoter polymorphism in anxiety related traits
65. Evidence for linkage disequilibrium between serotonin transporter protein gene (SLC6A4) and obsessive-compulsive disorder
66. Estradiol-17β increases serotonin transporter (SERT) mRNA levels and the density of SERT-binding sites in female rat brain
67. Are SSRI's safe for pregnant and breastfeeding women?
68. Serotonin regulates mouse cranial neural crest migration
69. Brain serotonin neurotransmission: An overview and update with an emphasis on serotonin subsystem heterogeneity, multiple receptors, interactions with other neurotransmitter systems, and consequent implications for understanding the actions of serotonergic drugs
70. Molecular manipulations as tools for enhancing our understanding of 5-HT neurotransmission
71. The short variant of the polymorphism within the promoter region of the serotonin transporter gene is a risk factor for late onset Alzheimer's disease
72. Barrel pattern formation requires serotonin uptake by thalamocortical afferents, and not vesicular monoamine release
73. Symptoms of eating disorders in patients with obsessive-compulsive disorder
74. Obsessive compulsive disorder: Comorbid conditions
75. Alzheimer's disease: Genetic studies and transgenic models
76. Abnormal trafficking and subcellular localization of an N-terminally truncated serotonin transporter protein
77. The future of genetic studies of complex human diseases
78. Searching for genetic determinants in the new millennium
79. 1B receptors disrupts the formation of sensory maps in monoamine oxidase A and 5-HT transporter knockout mice
80. Serotonergic mechanisms involved in the exploratory behavior of mice in a fully automated two-compartment black and white test box
81. Behavioral profiles of SSRIs in animal models of depression, anxiety and aggression: Are they alike?
82. Behavioural and pharmacological characterisation of the elevated "zero-maze" as an animal model of anxiety
83. Tourette's and comorbid syndromes: Obsessive-compulsive and attention deficit hyperactivity disorder. A common etiology?
84. Serotonin as a regulator of craniofacial morphogenesis: Site specific malformations following exposure to serotonin uptake inhibitors
85. Polymorphism within the promoter of the serotonin transporter gene and antidepressant efficacy of fluvoxamine
86. Molecular mechanisms of cocaine reward: Combined dopamine and serotonin transporter knockouts eliminate cocaine place preference
87. Polygenic genetic models: Adding serotonin to dopamine transporter knockouts enhances locomotion and increases weights
88. Cocaine reward models: Conditioned place preference can be established in dopamine- and in serotonin-transporter knockout mice
89. Neurobiology of the obsessive-compulsive spectrum disorders
90. Mechanisms mediating the increased anxiety-like behavior and excessive responses to stress in mice lacking the serotonin transporter
91. Genetic aspects of obsessive-compulsive disorder
92. Population choice in mapping genes for complex diseases
93. Efficacy of paroxetine in depression is influenced by a functional polymorphism within the promoter of the serotonin transporter gene